Loading data
CREXNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cost of revenue | 31.52 m USD | 26.84 m USD | 22.98 m USD | 25.61 m USD | 10.08 m USD |
| Gross profit | 25.71 m USD | 24.01 m USD | 22.18 m USD | 17.74 m USD | 8.36 m USD |
| Research and development expense | — | — | 1.57 m USD | 1.25 m USD | 550 k USD |
| Operating profit | -8.87 m USD | 938 k USD | 1.35 m USD | -2.48 m USD | -2.55 m USD |
| Interest expense | — | — | 2.99 m USD | 2.74 m USD | 805 k USD |
| Profit before tax | -7.11 m USD | -3.4 m USD | -2.85 m USD | 1.96 m USD | 254 k USD |
| Income tax expense | 1.17 m USD | 106 k USD | 83 k USD | 79 k USD | 22 k USD |
| Net income (reported basis) | -8.28 m USD | -3.51 m USD | -2.94 m USD | 1.88 m USD | 232 k USD |
| Net income attributable to common shareholders | -8.51 m USD | -3.51 m USD | — | — | — |
| Basic earnings per share | -0.81 USD/share | -0.34 USD/share | -0.35 USD/share | 0.28 USD/share | 0.06 USD/share |
| Diluted earnings per share | — | -0.34 USD/share | -0.35 USD/share | 0.28 USD/share | 0.06 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.